Company Filing History:
Years Active: 2015
Title: Innovations by Kideok Jin in Breast Cancer Treatment
Introduction
Kideok Jin, a prominent inventor based in Parkville, Maryland, has made significant strides in the field of cancer treatment, particularly focusing on tamoxifen-resistant breast cancer. His innovative approach involves targeting genetic factors contributing to drug resistance, showcasing the vital intersection of molecular biology and therapeutic advancements.
Latest Patents
Kideok Jin holds a key patent titled "Compositions and methods for treatment of tamoxifen resistant breast cancer." This patent introduces double-stranded short interfering nucleic acid (siNA) molecules that specifically target the HOXB7 gene. The research indicates that HOXB7 is frequently overexpressed in breast cancer and plays a crucial role in tamoxifen resistance. The methods outlined in this patent provide tools for screening, diagnosis, and predicting treatment outcomes, thereby enhancing therapeutic strategies for cancer patients.
Career Highlights
Kideok Jin is affiliated with The Johns Hopkins University, a leading institution in medical and scientific research. His work not only reflects a commitment to advancing cancer treatment but also positions him as an influential figure in academic circles. The single patent he has filed highlights his innovative contributions within his academic career.
Collaborations
In his pursuit of research excellence, Kideok Jin collaborates with Saraswati Vaidyanathan Sukumar, further enriching the scientific community with synergistic efforts to combat cancer. Their combined expertise emphasizes the importance of teamwork in fostering groundbreaking innovations in medical research.
Conclusion
Kideok Jin's pioneering work in the treatment of tamoxifen-resistant breast cancer exemplifies the vital innovations stemming from academic research. His patented inventions not only provide hope for patients but also underline the transformative potential of targeted therapies in the fight against cancer. As research continues to evolve, the contributions of inventors like Kideok Jin remain integral to advancing healthcare solutions.